Acute liver failure during pregnancy is a rare and potentially fatal occurrence. Sickle cell (SC) crises, when precipitated by pregnancy, usually affect patients with SC disease. We report a case of peripartum acute liver failure due to SC vaso-occlusive crisis of the liver in a patient with SC trait.
INTRODUCTION
Acute liver failure during pregnancy is a rare occurrence with potentially fatal outcomes. The most common etiologies include acute fatty liver of pregnancy (AFLP), with an incidence of B1/ 10 000 pregnancies, and HELLP syndrome (hemolysis, elevated liver enzymes and low platelets), with an incidence of B4/1000 deliveries. 1 Less common etiologies include Budd-Chiari syndrome and viral hepatitis. Though most African-American patients are screened for sickle cell (SC) status during pregnancy, SC trait is typically considered a benign carrier condition. Among AfricanAmericans, the prevalence of SC disease and SC trait are 1:400 and 1:12, respectively.
2 SC crises are often precipitated by pregnancy and can result in end-organ damage to the liver as well as other organ systems, yet these crises usually affect patients with SC disease. We report a case of peripartum acute liver failure due to SC vaso-occlusive crisis of the liver in a patient with SC trait.
CASE
A 32-year-old African-American G1P0 with a dichorionic-diamniotic gestation resulting from in vitro fertilization (IVF) underwent a planned primary low transverse cesarean section at 37 þ 3 weeks by IVF dating after presenting in labor. The cesarean was performed under spinal anesthesia, with an estimated blood loss of 900 ml; she received surgical prophylaxis with 2 g cefazolin. Infant A was male with APGARs of 8/9, weighing 2470 g. Infant B was male with APGARs of 9/9, weighing 2465 g. The pregnancy was otherwise uncomplicated. The patient's prenatal labs were: A þ , antibody-, Venereal Disease Research Laboratory-, HIV-, Group B Streptococcus-, hemoglobin 11.5 g/dl, Glucose Tolerance Test 94, and a new diagnosis of SC trait. Past medical history included migraines but no pain crises. Past surgical history included a diagnostic laparoscopy for suspected endometriosis, two dilation and curettages, and a tonsillectomy. Prenatal medications included zolpidem and prenatal vitamins. The patient had no known drug allergies, but did report lactose intolerance. Gynecologic history included one abnormal pap smear and no sexually transmitted infections. Social history was negative for tobacco, alcohol or drugs. The patient's postoperative course was initially routine, and she received the standard postpartum and postoperative medications, including the flu vaccine, ondansetron, colace, prenatal vitamin, zolpidem, hydromorphone, senekot and hydrocodone-acetaminophen 5/325. However, on postoperative day (POD) no. 1, patient was found to be lethargic and somnolent. Later that day she became disoriented and weak. A thorough workup ensued, revealing several abnormalities. Notable abnormal lab values are in Table 1 and normal lab tests are in Table 2 . The patient's normal imaging studies (Table 3) included: ultrasounds with doppler of the right upper quadrant, renal/ retroperitoneal and bilateral lower extremities; echocardiogram, flexible sigmoidoscopy, upper endoscopy and head computerized tomography (CT) with and without contrast. Abdominal CT without contrast revealed ileus and diffuse abdominal ascites.
The patient was diagnosed with acute liver failure, acute renal failure and metabolic acidosis. In the setting of elevated liver function tests, hypoglycemia, coagulopathy and hyperammonemia, AFLP was the presumed etiology, as HELLP, Budd-Chiari and viral hepatitis had been ruled out. She was transferred to our facility on POD no. 5 for potential liver transplant and promptly intubated for impending respiratory failure. She received two units of cryoprecipitate and was placed on a norepinephrine drip owing to persistent hypotension. She was consulted on by hematology, metabolism/ genetics, transplant surgery, nephrology and hepatology.
Liver biopsy revealed acute hepatitis with zone 3 necrosis, moderate congestion with probable red cell sickling and extramedullary hematopoiesis. However, the biopsy did not show classic microvesicular fat, fibrosis, viral inclusions, perivascular hemorrhage or fibrin deposition (Figures 1 and 2 ). This pattern was consistent with SC vaso-occlusive crisis of the liver and inconsistent with AFLP or HELLP syndrome.
Despite roughly 30% liver damage (as determined microscopically), the patient eventually recovered with mainly supportive care, and was discharged home on POD no. 22.
DISCUSSION
It is well-recognized that SC disease can be exacerbated by pregnancy due to its increased metabolic demands, hypercoagulable state and vascular stasis. Specifically, pregnant women with SC disease have higher risks of mortality, preeclampsia, abruption and sepsis, 3 as well as increased fetal risks of preterm delivery, growth restriction and fetal demise. There is even a case report of acute fulminant liver failure due to an intrahepatic vaso-occlusive crisis at 26 weeks gestation 4 in a woman with SC disease. In contrast, the literature does not show a similar association with SC trait. 5 The most robust study investigating the effect of SC trait on pregnancy outcomes compared over 3000 SC trait pregnancies to over 32 000 hemoglobin AA pregnancies in a single health system. The authors concluded that SC trait pregnancies had no increased risk of perinatal death, gestational hypertension pre-eclampsia, eclampsia, preterm birth, low birth weight, maternal peripartum infections (pyelonephritis, chorioamnionitis and endomyometritis) or 2nd trimester fetal loss. 5 Though SC trait patients rarely experience complications from their disease, our case report demonstrates that the physiological stresses of pregnancy can be associated with life-threatening complications, even in this class of patients with a carrier condition traditionally viewed as benign.
Acute liver failure in pregnancy is a rare occurrence and clinically challenging. The differential diagnosis is broad, and includes liver diseases specific to pregnancy, liver diseases worsened by pregnancy and liver diseases unassociated with, but occurring during, pregnancy. Physiologic, anatomic, and laboratory changes associated with pregnancy, in addition to ethical concerns of the fetus, further complicate the diagnosis and treatment of acute liver failure in pregnancy. 1 Much of the literature is isolated case reports or reviews of all liver disease in pregnancy.
Our patient's only risk factors for a vaso-occlusive crisis or liver dysfunction included: twin pregnancy, abdominal surgery and use of acetaminophen-containing pain relievers postpartum. We trust that our case report will serve to educate obstetric providers about potential grave complications of SC trait during pregnancy. Specifically, we would like to introduce vaso-occlusive crisis as a cause of acute liver dysfunction in pregnant patients with SC disease or trait. This case report suggests that a comprehensive evaluation of the gravida in hepatic failure may require a broadened list of differential diagnoses, with specific attention paid to her SC status. Given the frequency of SC trait, future population-level systematic examinations of these patients and their pregnancy outcomes may serve to uncover whether there is a measurable incidence of other adverse perinatal outcomes in these women.
